
21 patients with zzso zzso (8 zzso 4 zzso 4 zzso 5 zzso were treated with high dose therapy and zzso bone zzso rescue zzso At the time of zzso 12 patients were in zzso 6 in zzso and 3 in zzso zzso of the patients were at high risk at the time of zzso Before zzso patients received an zzso regimen such as zzso or zzso zzso zzso and 12 zzso zzso in 6 zzso In 9 patients the bone zzso was treated in zzso with zzso zzso and zzso The hospital stay was a median 33 zzso days and isolation 19 zzso zzso zzso were zzso zzso zzso zzso zzso infections zzso zzso zzso zzso and zzso zzso zzso Late complications (up to 6 months after zzso were zzso zzso zzso cerebral zzso zzso and zzso zzso zzso 10 of 19 zzso patients are alive and zzso zzso months zzso 10) after zzso and 3 of 10 more than 2 years later: 4 of 5 were transplanted in zzso zzso 4 of 6 in greater than or equal to zzso zzso and 2 of 8 in zzso 4 patients are living in therapy sensitive zzso 2, 11, 11 and 39 months after zzso in zzso zzso or zzso 5 patients died zzso zzso zzso months on zzso 2 of 21 from zzso The morbidity of zzso is comparable with conventional high dose zzso zzso survival was significantly influenced by the zzso status at zzso zzso survivors can be expected even in patients with high risk zzso zzso However, only wider trials will serve to establish the efficacy of zzso 

